c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics

Molecular and Cellular Biology

Volumn 30, Issue 15, 2010, Pages 3767-3778

  Adler, Julia ^a   Reuven, Nina ^a   Kahana, Chaim ^a   Shaul, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELLOBIOSE QUINONE OXIDOREDUCTASE; NITRITE REDUCTASE [NAD(P)H]; PROTEASOME; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; NICOTINAMIDE ADENINE DINUCLEOTIDE; NQO1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR; UBIQUITIN;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; EMBRYO; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN DEGRADATION; GENETICS; KINETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE;

PYRONIA TITHONUS;

KINETICS; NAD; NAD(P)H DEHYDROGENASE (QUINONE); PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-FOS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; UBIQUITIN;

EID: 77955286666     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00899-09     Document Type: Article

References (56)

1. Ahn, K. S., G. Sethi, A. K. Jain, A. K. Jaiswal, and B. B. Aggarwal. 2006. Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis. J. Biol. Chem. 281:19798-19808.
2. Asher, G., Z. Bercovich, P. Tsvetkov, Y. Shaul, and C. Kahana. 2005. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol. Cell 17:645-655. (Pubitemid 40320915)
3. Asher, G., J. Lotem, B. Cohen, L. Sachs, and Y. Shaul. 2001. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl. Acad. Sci. U. S. A. 98:1188-1193.
4. Asher, G., J. Lotem, L. Sachs, C. Kahana, and Y. Shaul. 2002. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc. Natl. Acad. Sci. U. S. A. 99:13125-13130.
5. Asher, G., J. Lotem, P. Tsvetkov, V. Reiss, L. Sachs, and Y. Shaul. 2003. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proc. Natl. Acad. Sci. U. S. A. 100:15065-15070.
6. Asher, G., N. Reuven, and Y. Shaul. 2006. 20S proteasomes and protein degradation "by default." Bioessays 28:844-849.
7. Asher, G., and Y. Shaul. 2005. p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle 4:1015-1018. (Pubitemid 41365353)
8. Asher, G., P. Tsvetkov, C. Kahana, and Y. Shaul. 2005. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 19:316-321. (Pubitemid 40189294)
9. Balch, W. E., R. I. Morimoto, A. Dillin, and J. W. Kelly. 2008. Adapting proteostasis for disease intervention. Science 319:916-919.
10. Basbous, J., D. Chalbos, R. Hipskind, I. Jariel-Encontre, and M. Piechaczyk. 2007. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol. Cell. Biol. 27:3936-3950.
11. Basbous, J., I. Jariel-Encontre, T. Gomard, G. Bossis, and M. Piechaczyk. 2008. Ubiquitin-independent versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer? Biochimie 90:296-305.
12. Bossis, G., P. Ferrara, C. Acquaviva, I. Jariel-Encontre, and M. Piechaczyk. 2003. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo. Mol. Cell. Biol. 23:7425-7436.
13. Bunz, F., A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J. P. Brown, J. M. Sedivy, K. W. Kinzler, and B. Vogelstein. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501.
14. Campbell, K. M., A. R. Terrell, P. J. Laybourn, and K. J. Lumb. 2000. Intrinsic structural disorder of the C-terminal activation domain from the bZIP transcription factor Fos. Biochemistry 39:2708-2713.
15. Campos, M. A., E. G. Kroon, R. Gentz, and P. C. Ferreira. 1999. Protein domains involved in nuclear transport of Fos. Cell Biol. Int. 23:81-88.
16. Chida, K., S. Nagamori, and T. Kuroki. 1999. Nuclear translocation of Fos is stimulated by interaction with Jun through the leucine zipper. Cell. Mol. Life Sci. 55:297-302.
17. Chowdary, D. R., J. J. Dermody, K. K. Jha, and H. L. Ozer. 1994. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 14:1997-2003.
18. Deng, T., and M. Karin. 1994. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 371: 171-175. (Pubitemid 24284018)
19. Dhakshinamoorthy, S., and A. K. Jaiswal. 2000. Small Maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:quinone oxidoreductase1 gene. J. Biol. Chem. 275:40134-40141.
20. Dunker, A. K., C. J. Brown, J. D. Lawson, L. M. Iakoucheva, and Z. Obradovic. 2002. Intrinsic disorder and protein function. Biochemistry 41:6573-6582.
21. Dyson, H. J., and P. E. Wright. 2005. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6:197-208.
22. Edlund, C., A. Elhammer, and G. Dallner. 1982. Distribution of newly synthesized DT-diaphorase in rat liver. Biosci. Rep. 2:861-865.
23. Eferl, R., and E. F. Wagner. 2003. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3:859-868.
24. Ferrara, P., E. Andermarcher, G. Bossis, C. Acquaviva, F. Brockly, I. Jariel-Encontre, and M. Piechaczyk. 2003. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression. Oncogene 22:1461-1474. (Pubitemid 36390595)
25. Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin-proteasome pro- teolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:373-428.
26. Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-Fos proto-oncogene. Nature 311:433-438.
27. Hershko, A. 1996. Lessons from the discovery of the ubiquitin system. Trends Biochem. Sci. 21:445-449.
28. Jaiswal, A. K. 2004. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 36:1199-1207.
29. Jaiswal, A. K. 2000. Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic. Biol. Med. 29:254-262.
30. Jariel-Encontre, I., G. Bossis, and M. Piechaczyk. 2008. Ubiquitin-independent degradation of proteins by the proteasome. Biochim. Biophys. Acta 1786:153-177.
31. Kahana, C., G. Asher, and Y. Shaul. 2005. Mechanisms of protein degradation: an odyssey with ODC. Cell Cycle 4:1461-1464.
32. Kruijer, W., J. A. Cooper, T. Hunter, and I. M. Verma. 1984. Platelet-derived growth factor induces rapid but transient expression of the c-Fos gene and protein. Nature 312:711-716.
33. Li, Y., and A. K. Jaiswal. 1992. Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J. Biol. Chem. 267:15097-15104.
34. Malnou, C. E., F. Brockly, C. Favard, G. Moquet-Torcy, M. Piechaczyk, and I. Jariel-Encontre. 2010. Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution. J. Biol. Chem. 285: 6552-6562.
35. Mamroud-Kidron, E., M. Omer-Itsicovich, Z. Bercovich, K. E. Tobias, E. Rom, and C. Kahana. 1994. A unified pathway for the degradation of ornithine decarboxylase in reticulocyte lysate requires interaction with the polyamine-induced protein, ornithine decarboxylase antizyme. Eur. J. Biochem. 226:547-554.
36. Mao, I., J. Liu, X. Li, and H. Luo. 2008. REGgamma, a proteasome activator and beyond? Cell. Mol. Life Sci. 65:3971-3980.
37. Monje, P., M. J. Marinissen, and J. S. Gutkind. 2003. Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signalregulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol. Cell. Biol. 23:7030-7043.
38. Murphy, L. O., S. Smith, R. H. Chen, D. C. Fingar, and J. Blenis. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4:556-564.
39. Nioi, P., and J. D. Hayes. 2004. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat. Res. 555:149-171.
40. Papavassiliou, A. G., M. Treier, C. Chavrier, and D. Bohmann. 1992. Targeted degradation of c-Fos, but not v-Fos, by a phosphorylation-dependent signal on c-Jun. Science 258:1941-1944.
41. Ross, D., and D. Siegel. 2004. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol. 382: 115-144.
42. Roux, P., J. M. Blanchard, A. Fernandez, N. Lamb, P. Jeanteur, and M. Piechaczyk. 1990. Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell 63:341-351. (Pubitemid 20355455)
43. Salvat, C., C. Acquaviva, M. Scheffner, I. Robbins, M. Piechaczyk, and I. Jariel-Encontre. 2000. Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Requirements upon different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo. Eur. J. Biochem. 267:3712-3722.
44. Sasaki, T., H. Kojima, R. Kishimoto, A. Ikeda, H. Kunimoto, and K. Nakajima. 2006. Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol. Cell 24:63-75. (Pubitemid 44466681)
45. Schuermann, M., M. Neuberg, J. B. Hunter, T. Jenuwein, R. P. Ryseck, R. Bravo, and R. Muller. 1989. The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell 56:507-516.
46. Sollner, S., R. Nebauer, H. Ehammer, A. Prem, S. Deller, B. A. Palfey, G. Daum, and P. Macheroux. 2007. Lot6p from Saccharomyces cerevisiae is a FMN-dependent reductase with a potential role in quinone detoxification. FEBS J. 274:1328-1339. (Pubitemid 46246611)
47. Sollner, S., M. Schober, A. Wagner, A. Prem, L. Lorkova, B. A. Palfey, M. Groll, and P. Macheroux. 2009. Quinone reductase acts as a redox switch of the 20S yeast proteasome. EMBO Rep. 10:65-70.
48. Stancovski, I., H. Gonen, A. Orian, A. L. Schwartz, and A. Ciechanover. 1995. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol. Cell. Biol. 15:7106-7116.
49. Tompa, P. 2005. The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett. 579:3346-3354. (Pubitemid 40804685)
50. Tsurumi, C., N. Ishida, T. Tamura, A. Kakizuka, E. Nishida, E. Okumura, T. Kishimoto, M. Inagaki, K. Okazaki, N. Sagata, et al. 1995. Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol. Cell. Biol. 15:5682-5687.
51. Tsvetkov, P., G. Asher, A. Paz, N. Reuven, J. L. Sussman, I. Silman, and Y. Shaul. 2008. Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome. Proteins 70:1357-1366. (Pubitemid 351304095)
52. Tsvetkov, P., N. Reuven, and Y. Shaul. 2009. The nanny model for IDPs. Nat. Chem. Biol. 5:778-781.
53. Uversky, V. N., J. R. Gillespie, and A. L. Fink. 2000. Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41: 415-427.
54. Vesely, P. W., P. B. Staber, G. Hoefler, and L. Kenner. 2009. Translational regulation mechanisms of AP-1 proteins. Mutat. Res. 682:7-12.
55. Wilkinson, J., IV, V. Radjendirane, G. R. Pfeiffer, A. K. Jaiswal, and M. L. Clapper. 1998. Disruption of c-Fos leads to increased expression of NAD-(P)H:quinone oxidoreductase 1 and glutathione S-transferase. Biochem. Biophys. Res. Commun. 253:855-858.
56. Winski, S. L., Y. Koutalos, D. L. Bentley, and D. Ross. 2002. Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells. Cancer Res. 62:1420-1424.